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Abstract
 
The mechanisms that control neural stem and progenitor cell survival are unknown. In several
pathological conditions, death receptor (DR) ligands and inflammatory cytokines exert a delete-
rious effect on neurons, whereas primitive neural cells migrate and survive in the site of lesion.
Here, we show that even in the presence of inflammatory cytokines, DRs are unable to generate
death signals in primitive neural cells. Neural stem and progenitor cells did not express caspase 8,
the presence of which is required for initiating the caspase cascade. However, exogenous or
cytokine-mediated expression of caspase 8 was not sufficient to restore their DR sensitivity.
Searching for molecules potentially able to block DR death-inducing signaling complex
(DISC), we found that primitive neural cells expressed high levels of the death effector domain-
containing protein PED (also known as PEA-15). PED localized in the DISC and prevented
caspase 8 recruitment and activation. Moreover, lentiviral-mediated delivery of PED antisense
DNA resulted in dramatic down-regulation of the endogenous gene expression and sensitization
of primitive neural cells to apoptosis mediated by inflammatory cytokines and DRs. Thus, absence
of caspase 8 and high expression of PED constitute two levels of protection from apoptosis induced
by DRs and inflammatory cytokines in neural stem and progenitor cells.
Key words: neural stem cells • apoptosis • inflammatory cytokines • death receptors • 
death-inducing signaling complex
 
Introduction
 
Neural stem cells are primitive cells able to undergo self-
renewal and generate the neural progeny through asym-
metric divisions (1, 2). These cells are responsible for the
development of the nervous system and contribute to adult
neurogenesis (3–5). In the adult brain, neural stem and pro-
genitor cells are primarily localized in the subventricular
zone and migrate to the olfactory bulb, which is the pri-
mary source for the isolation of primitive neural cells from
adult individuals (6–8). Primitive neural cells can be grown
in vitro as neurospheres, which are clusters of undifferenti-
ated cells containing a minority of neural stem cells and a
high number of progenitors able to produce astrocytes,
neurons, and oligodendrocytes upon exposure to differen-
tiating agents (9).
Neural stem and progenitor cells apoptosis play a major
role in the development of the nervous system. However,
the mechanisms that control the survival of undifferentiated
neural cells are poorly understood. Two major apoptotic
pathways generate death signals in mammalian cells. The
intrinsic pathway involves the release of apoptotic media-
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tors from mitochondria with the formation of a high mo-
lecular weight complex containing cytochrome 
 
c
 
, Apaf-1,
and caspase 9, which activates caspase 3 and the execution
phase of apoptosis. The extrinsic pathway is activated by
death receptors (DRs), a widely expressed subgroup of the
TNF receptor superfamily able to transduce apoptotic sig-
nals. After ligand binding, the recruitment of the adaptor
protein FADD and caspase 8 to DRs leads to the formation
of the death-inducing signaling complex (DISC; reference
10), resulting in activation and processing of caspase 8 and
downstream effector caspases (11). DR signaling can be re-
duced or neutralized by the presence of high levels of
cFLIP (12) or PED/PEA-15 (13), two DR inhibitory pro-
teins that interact with FADD and caspase 8 through their
DED domains, thus preventing caspase 8 activation.
Experimental evidences obtained with knockout mice
indicate that neuronal cell ablation during development oc-
curs through the activation of the intrinsic apoptotic path-
way, as mice lacking caspase 9 (14, 15) or the caspase adap-
tor Apaf-1 (16, 17) have abnormal neuronal growth and
severe neurological malformations. In contrast, mice lack-
ing caspase 8 do not have neuronal defects (18), suggesting
that the extrinsic apoptotic pathway is not exploited during
this process. The strict developmental dependence on the
intrinsic apoptotic pathway may be related to a possible de-
ficiency of the DR/ligand expression or signaling in em-
bryonic neural stem and progenitor cells.
DRs may contribute to neuronal death in several acute
pathological conditions, such as brain ischemia or traumatic
head injury. Neutralization of CD95 (Fas/APO-1) ligand
(CD95L) and TNF-
 

 
 protects from stroke-induced neuro-
degeneration by attenuating reperfusion damage and in-
creasing neuronal viability (19, 20). Similarly, CD95L
blockade significantly reduces neuronal and oligodendro-
cytic apoptosis and promotes functional recovery in spinal
cord–lesioned mice (21). Moreover, CD95 up-regulation
and caspase 8 activation has been consistently observed in
human brain after severe traumatic injury (22). The inflam-
matory events occurring after acute brain damage are
thought to cooperate with DRs for neuronal destruction
(23). Glial cells can actively contribute to this process
through the release of inflammatory cytokines, such as
TNF-
 

 
, IL-1
 

 
, and IFN-
 

 
, which may prime neurons to
DR-mediated apoptosis.
After neural cell death, endogenous progenitors may dif-
ferentiate and restore the damaged areas. The increased
number of neural progenitor cells (NPCs) observed in
acute neuronal lesions results from enhanced proliferation
and migration to the injured region (24). Therefore, NPCs
survive and differentiate in the sites of acute neurodegener-
ation under the harmful presence of inflammatory media-
tors and DR ligands, again suggesting that the extrinsic
pathway is defective in primitive neural cells.
The possible impairment of DR signaling in both em-
bryonic and adult NPCs prompted us to investigate the in-
tegrity of the extrinsic pathway in primitive neural cells and
their progeny. Here, we show that NPCs display a double
level of protection from DR-induced apoptosis, which
neutralizes the combined proapoptotic activities of DR
ligands and inflammatory cytokines.
 
Materials and Methods
 
Cell Cultures. 
 
Human embryonic tissue was obtained from
the brains of 12-wk-old embryos legally aborted, according to
the ethical guidelines of the European Network for Transplanta-
tion (NECTAR). The ethical committee of “C. Besta” Neuro-
logical Institute and of the “L. Mangiagalli” Obstetric-Gyneco-
logical Clinic authorized the use of human central nervous system
tissue. Human neural adult tissue was obtained following the eth-
ical guidelines of the NECTAR and the Declaration of Helsinki
from patients undergoing particularly invasive neurosurgery.
NPCs were isolated from human tissues as described previously
(25–27). NPCs were cultured in the presence of 20 ng/ml of hu-
man recombinant epidermal growth factor and 10 ng/ml of hu-
man recombinant basic fibroblast growth factor in a NS-A basal
serum-free medium (Euroclone) containing 2 mM 
 
l
 
-glutamine,
0.6% glucose, 9.6 
 

 
g/ml putrescine, 6.3 ng/ml progesterone, 5.2
ng/ml sodium selenite, 0.025 mg/ml insulin, and 0.1 mg/ml
transferrin sodium salt (Sigma-Aldrich). Alternatively, commer-
cial NPCs were purchased from BioWhittaker and cultured ac-
cording to the manufacturer’s protocols. Both commercial and
tissue-purified NPCs were used from passage 5 to 15 throughout
the study. These cells expressed the progenitor marker nestin
(
 

 
99%) and were essentially negative for neuronal and glial anti-
gens (
 

 
2%), as evaluated by immunofluorescence staining and
confocal microscopy analysis. The NT2/D1 cell line was grown
in DMEM (GIBCO BRL) supplemented with 10% heat-inacti-
vated FBS (Hyclone Laboratories). NT2/D1 differentiation into
postmitotic neurons (referred to as NT2-N cells) was performed
as described previously (28). In brief, 2 
 

 
 10
 
6
 
 cells were plated in
a 75-cm
 
2
 
 flask and treated with 10 
 

 
M retinoic acid (RA; Sigma-
Aldrich) twice a week for 4 wk. After retinoic acid treatment,
cells were seeded in DMEM with 10% FBS at a reduced density.
After 48 h, day-0 (neuronal progenitor) NT2-N cells were me-
chanically dislodged and replated on Matrigel (Becton Dickinson)
in DMEM with 10% FBS supplemented with 1 
 

 
M cytosine ara-
binoside, 10 
 

 
M fluorodeoxyuridine, and 10 
 

 
M uridine (Sigma-
Aldrich) for 4 wk, until terminal differentiation. The human neu-
roblastoma SK-N-AS, T lymphoblastoid HuT-78, T lymphoma
Jurkat, and monocytic U937 cell lines were cultured in RPMI
1640 medium (GIBCO BRL) supplemented with 10% FBS (Hy-
clone Laboratories).
 
Antibodies and Flow Cytometry. 
 
To detect surface DRs ex-
pression, 5 
 

 
 10
 
4
 
 NPCs were washed twice with cold PBS
and incubated for 1 h at 4
 

 
C with 10 
 

 
g/ml of antibodies spe-
cific to CD95 (DX2, mouse IgG
 
1
 
, DakoCytomation), TNFR1
(16805.21, mouse IgG
 
1
 
; R&D Systems), TRAIL-R1/DR4 (AF347,
goat IgG; R&D Systems), TRAIL-R2/DR5 (AF631, goat IgG,
R&D Systems), or control antibody. After two washes, cells were
stained for 30 min with fluorescein isothiocyanate–conjugated
anti–mouse or anti–goat secondary antibodies (Jackson Immu-
noResearch Laboratories). Cytometric staining was analyzed on a
FACSCalibur Instrument (Becton Dickinson), and data were ana-
lyzed with CELLQuest software (Becton Dickinson).
 
Cell Death Quantification. 
 
To minimize the effects of growth
factors on the survival of NPCs, epidermal growth factor and ba-
sic fibroblast growth factor were removed from the culture me-
dium 2 h before DR stimulation. Apoptotic death was assessed by
DNA staining and flow cytometry. In brief, cells were incubated
overnight at 4
 

 
C in a propidium iodide solution (50 
 

 
g/ml) with
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0.1% sodium citrate and 0.1% Triton X-100, until flow cytomet-
ric analysis. The percentage of apoptotic cells was determined by
evaluating the number of hypodiploid nuclei. Alternatively, cell
death was evaluated by using the CellTiter 96 AQ
 
ueous
 
 One Solution
Cell Proliferation Assay (Promega) according to the manufacturer’s
protocol. The assay is based on reduction of 3-(4,5-dimethylthia-
zol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tet-
razolium, inner salt (MTS) to a colored formazan product that is
measured spectrophotometrically. Cells were plated in 96-well
plates in triplicate, stimulated, and incubated at 37
 

 
C in a 5%
CO
 
2
 
 incubator. Metabolically active cells were detected by add-
ing 20 
 

 
l of MTS to each well. After 2 h of incubation, the plates
were red on a Multilabel Counter (Victor2; PerkinElmer). Before
the apoptotic assays, cell viability was routinely evaluated at single
cell level by ethidium bromide–acridine orange staining and fluo-
rescence microscopy analysis (29).
 
Immunoblot Analysis and RNase Protection Assay.
 
Cell pellets
were washed twice with cold PBS, resuspended in a 50-mM Tris-
HCl, pH 7.5, 200 mM NaCl, and 1% NP-40 ice-cold buffer con-
taining proteinase inhibitor cocktail (Sigma-Aldrich), and incu-
bated for 30 min on ice. After centrifugation at 10,000 
 
g
 
 for 10
min, lysates were collected as supernatants. For each sample, 20
 

 
g of cell extracts was resolved on a 12% SDS-polyacrylamide gel
using a mini-gel apparatus (Bio-Rad Laboratories) and transferred
to Hybond-C extra nitrocellulose (Amersham Biosciences). Mem-
brane was blocked for 1 h with 5% nonfat dry milk in TBS
containing 0.05% Tween-20 and incubated for 2 h with specific
antibodies. The following antibodies were used for immunoblot-
ting: anti–caspase 8 (5F7, mouse IgG
 
2b
 
; Upstate Biotechnology);
anti–caspase 3 (rabbit polyclonal IgG; Upstate Biotechnology);
anti-FADD (mouse IgG1; Transduction Laboratories); anti-CD95
(C-20, rabbit polyclonal IgG; Santa Cruz Biotechnology, Inc.);
anti-FLIP (NF6, mouse IgG
 
1
 
; Qbiogene); anti-PED/PEA-15 se-
rum as described previously (30); anti–caspase 9 (goat IgG; R&D
Systems); and anti–
 

 
-actin (Ab-1, mouse IgM; Oncogene Re-
search Products). Washed filters were incubated for 45 min with
horseradish peroxidase–conjugated anti–rabbit or anti–mouse sec-
ondary antibodies (Amersham Biosciences) and visualized by using
an enhanced chemiluminescence detection system (SuperSignal
West Pico chemiluminescent substrate; Pierce Chemical Co.).
Total RNA was isolated from cells using RNeasy
 
 
 
kit (QIAGEN).
mRNA levels were evaluated using Riboquant Multi-Probe
RNase Protection Assay System (hAPO-1c and hAPO-3c; BD
Biosciences) according to the manufacturer’s protocols.
 
Immunofluorescence Microscopy.
 
Cells were grown on poly-
lysine-coated glass coverslips for immunofluorescence micros-
copy. After a fixing step in 2% paraformaldehyde-PBS for 20 min
at 37
 

 
C, cells were permeabilized in 0.2% Triton X-100 PBS for
3 min and washed three times for 5 min with PBS. Slides were
incubated for 1 h at 37
 

 
C with anti–caspase 8 (N-19, goat poly-
clonal IgG; Santa Cruz Biotechnology, Inc.) and antineuron-spe-
cific 
 

 
-III tubulin–specific antibodies (mouse IgG
 
1
 
; Serotec Inc.).
Nuclei were counterstained with propidium iodide (Sigma-
Aldrich). After two washes in PBS, slides were incubated with
secondary antibodies for 45 min at 37
 

 
C. Secondary antibodies,
including FITC-conjugated goat anti–mouse IgG and Cy5-con-
jugated donkey anti–goat IgG, (Jackson ImmunoResearch Labo-
ratories) were used at 2.5 
 

 
g/ml. Images were collected with a
laser scanning microscope (IX81; Olympus).
 
Transduction of NPCs with Lentiviral Vectors. 
 
Gene transfer
was performed by using pRRLsin.cPPT.hCMV.GFP.Wpre and
pRRLsin.cPPT.hPGK.GFP.Wpre, new variants of third-genera-
tion lentiviral vectors described previously (31). To simulta-
neously transduce both reporter and target gene, a new lentivi-
ral vector, Tween, was generated by engineering pRRLsin.cPPT.
hCMV.GFP.Wpre. In this vector, the hCMV.GFP cassette was
substituted with the hCMV.hPGK.GFP. A multiple cloning site
was inserted downstream of hCMV. Caspase 8 cDNA was sub-
cloned in the XhoI site of Tween vector. PED/PEA-15 antisense
was obtained by PCR amplification of the human PED/PEA-15
Figure 1. Expression of DRs and sensitivity to apoptosis in tissue-isolated
embryonic and adult NPCs. (A) Flow cytometry analysis of DRs in
NPCs. Cells were stained with antibodies specific to CD95, TNFR1,
TRAIL-R1/DR4 and TRAIL-R2/DR5 (gray), or control IgGs (black).
(B) Percentage of apoptotic cells in NPCs untreated (Ctrl) or exposed for
24 h to 500 ng/ml anti-CD95 (CH11), 500 U/ml TNF-, 500 ng/ml
TRAIL, or 0.25 M staurosporine (Stauro). The human monocytic cells
U937 were used as a positive control. The results are the mean 	 SD of
four independent experiments. (C) Immunoblot analysis of caspase 8
(Casp 8), caspase 3 (Casp 3), and FADD on embryonic (E-NPCs) and
adult NPCs (A-NPCs) as compared with control cell lines. Detection of
-actin in the same membrane blot served as loading control. One repre-
sentative experiment out of four is shown.
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cDNA using the following primers: 5
 


 
-CCCGCTAGCGCT-
CAATGTAGGAGAGGTTG-3
 


 
 and 5
 


 
-CCCCTCGAGGCC-
AGAGCGCGCGGGGCAGTGTG-3
 


 
 containing the NheI and
XhoI cloning sites, respectively (32). The amplified fragment was
subcloned in the XbaI site of the Tween vector.
Lentiviral supernatants were produced by calcium phosphate
transient cotransfection of a three-plasmid expression system in
the packaging human embryonic kidney cell line 293T. The
calcium-phosphate DNA precipitate was removed after 14–16 h
by replacing the medium. Viral supernatant was collected 48 h
after transfection, filtered through 0.45 
 

 
m–pore nitrocellulose
filters, and frozen in liquid nitrogen. On the same day of trans-
fection, NPCs were plated in a six-well plate in presence of
viral supernatant. 4 
 

 
g/ml of polybrene was added to the viral
supernatant to improve the infection efficiency (31). Cells
were centrifuged for 45 min at 1,800 revolutions/min and in-
cubated for 75 min in a 5% CO
 
2 
 
incubator. After the infection
cycles, NPCs were washed twice and replated in fresh
medium. Infection efficiency was evaluated after 48 h by flow
cytometry.
 
DISC Analysis by Immunoprecipitation.
 
NPCs were pretreated
with 200 U/ml of human recombinant TNF-
 

 
, 500 U/ml
IFN-
 

 
, and 100 U/ml IL-1
 

 
 (PeproTech) for 60 h and stimu-
lated with 1 
 

 
g/ml of CD95 agonistic antibody (CH11, mouse IgM;
Upstate Biotechnology) for 90 min at 37
 

 
C in a 5% CO
 
2
 
 incuba-
tor. In unstimulated controls, 100 ng of CH11 was added after
lysis in NP-40 lysis buffer to immunoprecipitate nonstimulated
DRs. 15 
 

 
g of total proteins were immunoprecipitated with goat
anti–mouse IgM antibody (Abcam Ltd.) bound to protein A/G–
Sepharose beads (Pierce Chemical Co.) overnight at 4
 

 
C. Immu-
noprecipitates were washed three times with lysis buffer, mixed
with 20 
 

 
l of 2 
 

 
 Laemmli sample buffer, boiled for 10 min, and
analyzed by Western blotting for the presence of CD95, Caspase
8, FADD, and PED/PEA-15.
 
Results
 
NPCs Are Resistant to DR-induced Apoptosis and Do Not
Express Caspase 8.
 
To investigate the role of the extrinsic
cell death pathway, we evaluated DR expression and apop-
tosis sensitivity in adult and embryonic NPCs. Flow cyto-
metric analysis showed that CD95 and TRAIL-R2/DR5
were highly expressed in the majority of NPCs, whereas the
levels of TRAIL-R1/DR4 and TNFR1 were lower (Fig. 1
A). This expression pattern was compatible with the ability
of DRs to transduce apoptotic signals. Therefore, we mea-
sure the viability of undifferentiated NPCs exposed to anti-
CD95 agonistic antibody, TNF-
 

 
 and TRAIL. Unlike the
control cell line U937, NPCs were completely resistant to
DR stimulation (Fig. 1 B), whereas NPCs exposed to stau-
rosporine exhibited massive apoptosis, suggesting the func-
tional integrity of the intrinsic death pathway and common
downstream components of both pathways (33).
This observation led us to evaluate the expression and
function of the upstream mediators of the extrinsic path-
way, whose possible impairment could account for NPC
resistance to DR-induced cell death. Western blot analysis
of major DISC components showed that FADD was ex-
Figure 2. Expression of caspase 8 during NPC and
NT2/D1 differentiation. (A) RNase protection assay
for caspase 8 mRNA in NPCs and NT2-neurons at
different days of differentiation. L32 levels were used as
loading control, and RNA of HeLa cells were used as
reference control. (B) Immunoblot analysis of caspase 8
expression in cells treated as in A. Cell lysates of HuT-78
cells were used as control. (C) Cells from differentiated
embryonic and adult NPCs were analyzed by confocal
microscopy to detect -III tubulin (green), caspase 8
(blue), and DNA (red). One representative experiment
out of four performed with commercial and tissue-isolated
NPCs is shown.
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pressed in both embryonic and adult NPCs, whereas cas-
pase 8 was not detectable (Fig. 1 C), suggesting that the ab-
sence of caspase 8 does not allow the activation of the
caspase cascade after DR triggering. In contrast, in line
with the assumed integrity of the downstream apoptotic
machinery, the executioner caspase 3 was expressed at high
levels as compared with those observed in DR-sensitive
neural or hematopoietic cells (Fig. 1 C).
 
Caspase 8 Expression during Neuronal Differentiation.
 
Next,
we analyzed the expression of caspase 8 in NPCs under-
going serum-induced differentiation. RNase protection
assay and immunoblot analysis revealed barely detectable
levels of caspase 8 mRNA and protein that increased dur-
ing NPC differentiation (Fig. 2, A and B). Serum-induced
NPC differentiation generates a population mainly com-
posed of astrocytes, whereas a low percentage (
 

 
15%) of
differentiated cells displays a neuronal phenotype. Because
mature astrocytes do not express caspase 8 (34), it is likely
that the limited increase in caspase 8 levels may reflect the
low proportion of neuronal cells generated by this system.
Therefore, the same molecular analysis was performed on
differentiating NT2/D1 cells. This cell line was derived
from a human germ cell tumor and consists of progenitors
cells that gradually differentiate into a virtually pure popu-
lation of neuronlike cells upon exposure to retinoic acid
(35, 36). Like NPCs, undifferentiated NT2-N cells ex-
pressed extremely low levels of caspase 8 mRNA and pro-
tein. However, caspase 8 levels dramatically increased dur-
ing neuronal differentiation, indicating that the presence of
caspase 8 in neurons is a developmentally regulated process
(Fig. 2, A and B). Accordingly, three-color fluorescence
and confocal analysis of differentiating NPCs showed that
caspase 8 was expressed only in cells positive for the neu-
ron-specific marker 
 

 
III-tubulin (Fig. 2 C), indicating that
Figure 3. Effect of inflammatory cytokines
on CD95 signaling in NPCs and differentiated
neurons. (A) RNase protection assay for caspase
8 and CD95 mRNAs on 28-d NT2-neurons
and NPCs untreated (Control) or treated with
200 U/ml TNF-, 500 U/ml IFN-, 100 U/ml
IL-1, or a mixture of the three cytokines
(Mix). L32 levels were used as loading control,
and RNA of HeLa cells were used as reference
control. (B) Immunoblot analysis of caspase 8
and CD95 expression on NT2-neurons and
NPCs treated as in A. Cell lysates of HuT-78
and Jurkat cells were used as control. Detection
of -actin in the same membrane blot served as
loading control. One representative experiment
out of three performed with commercial and
tissue-isolated embryonic NPCs is shown. (C)
Percentage of apoptotic cells from NT2-neurons
and NPCs exposed to anti-CD95 and to the
cytokine mix as indicated. The results represent
the mean of four independent experiments, using
tissue-isolated embryonic and adult NPCs.
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primitive neural cells acquire the expression of caspase 8
during neuronal differentiation.
 
Inflammatory Cytokines Do Not Sensitize NPCs to CD95-
mediated Apoptosis.
 
During serum-induced differentia-
tion, NPCs exposed to inflammatory cytokines give rise to
reactive astrocytes, which are sensitive to CD95 stimulation
(37 and unpublished data). Given the ability of inflamma-
tory molecules to up-regulate caspase 8 in different cellular
systems, we exposed neurons and NPCs to TNF-
 

 
, IFN-
 

 
,
IL-1
 

 
, or to the combinations of the three inflammatory
cytokines and analyzed the expression of CD95 DISC
components and susceptibility to apoptosis. RNase protec-
tion and immunoblot analysis showed that exposure of
NT2-derived neurons to each single cytokine was suffi-
cient to significantly up-regulate CD95 and caspase 8 ex-
pression (Fig. 3, A and B), suggesting that the presence
of inflammatory cytokines may prime neurons to DR-
induced apoptosis. Differently from neurons, exposure of
NPCs to single inflammatory cytokines resulted in limited
up-regulation of caspase 8 and CD95. However, simulta-
neous exposure of NPCs to TNF-
 

 
, IFN-
 

 
, and IL-1
 

 
potently up-regulated both CD95 and caspase 8, suggesting
a synergistic effect of different inflammatory stimuli (Fig. 3,
A and B). Although the majority of NT2 neurons under-
went apoptosis after CD95 stimulation in the presence of
inflammatory cytokines, despite the presence of cytokine-
induced caspase 8, NPCs remained completely refractory
to CD95 stimulation (Fig. 3 C), thus suggesting that the
absence of caspase 8 is not the only antiapoptotic feature
responsible for DR refractoriness of NPCs.
 
Exogenous Caspase 8 Expression Does Not Prime NPCs to
DR-induced Apoptosis.
 
To confirm that the absence of
NPC sensitivity to DR-induced apoptosis was not exclu-
sively due to the absence of caspase 8, NPCs were trans-
duced with a lentiviral vector carrying caspase 8a cDNA
and the GFP as a reporter. After infection, NPCs trans-
duced with control vector or caspase 8 were analyzed by
flow cytometry. As shown in Fig. 4 A, the lentiviral infec-
tion yielded an essentially pure population of GFP positive
cells. The expression of caspase 8 was further monitored by
immunoblot analysis, which revealed that the exogenous
expression of caspase 8 was comparable to that induced in
NPCs by the combined treatment with TNF-
 

 
, IFN-
 

 
,
and IL-1
 

 
 (Fig. 4 B). In line with the experiments con-
cerning cytokine induction of caspase 8, exogenous caspase
8 expression was not sufficient to sensitize NPCs to CD95-
mediated apoptosis, whereas the cells remained equally re-
sponsive to staurosporine (Fig. 4 C). To investigate
whether the inability to transduce apoptotic signals by DR-
stimulated NPCs, expressing endogenous or exogenous
caspase 8, resulted from a defect at the DISC level, we di-
rectly analyzed caspase 8 processing after CD95 stimula-
tion. Immunoblot analysis of NPCs transduced with cas-
pase 8 or stimulated with TNF-
 

 
, IFN-
 

 
, and IL-1
 

 
showed no caspase 8 processing, whereas the control cell
line HuT-78 displays massive caspase 8 degradation with
formation of the canonical fragments of 43-41 and 20 kD
(Fig. 4 D). These data suggest that in addition to the ab-
Figure 4. Absence of sensitization to CD95-induced apoptosis by exoge-
nous caspase 8 expression in adult NPCs. (A) Flow cytometry profiles of
GFP-positive NPCs transduced with empty Tween (Vector) or Tween/
Caspase 8 (Caspase 8) vector (gray) as compared with nontransduced
NPCs (black). (B) Immunoblot analysis of caspase 8 and -actin in NPCs
transduced as in A or treated with TNF-, IFN-, and IL-1 (Mix). Jur-
kat and HuT-78 cell lines were used as positive controls. (C) Percentage
of apoptosis in NPCs transduced as in A and treated with anti-CD95 or
staurosporine. HuT-78 cells were used as positive control. The results are
the mean 	 SD of four independent experiments. (D) Immunoblot analysis
of caspase 8 and -actin in NPCs cultured with or without inflammatory
cytokines and exposed to anti-CD95 for 12 or 24 h. In the control cell
line HuT-78, the proteolytic products of caspase 8 were detectable
shortly after CD95 stimulation.
sence of caspase 8, NPCs have a second mechanism operat-
ing at the DISC level responsible for early impairment of
the apoptosis signaling generated by DRs.
PED/PEA-15 Mediates NPC Resistance to Inflammatory
Cytokines and DR Stimulation. The lack of caspase 8
processing after CD95 stimulation in caspase 8–expressing
NPCs may result from the inhibitory action of antiapoptotic
Ricci-Vitiani et al.1263
factors that act at the DISC level. Immunoblot analysis of
those antiapoptotic proteins that block the caspase activation
cascade through inhibition of caspase 8 activation showed
that cFLIP was expressed at low levels in NPCs, whereas
PED/PEA-15 was strongly expressed (Fig. 5, A and B) and
not influenced by the presence of exogenous caspase 8.
Next, we investigated whether inflammatory cytokines
could modulate PED/PEA-15 expression in undifferenti-
ated NPCs or in neurons. Exposure of NPCs to IFN or
IL-1 considerably increased PED/PEA-15 expression (Fig.
5 C). In contrast, treatment with inflammatory cytokines
resulted in dramatic downmodulation of PED/PEA-15 ex-
pression in neurons (Fig. 5 D). The opposite effect gener-
ated by inflammatory cytokines on PED/PEA-15 expres-
sion in NPCs and in differentiated neurons was in line with
their inability to restore NPC sensitivity to DR-mediated
apoptosis, despite the significant induction of caspase 8. To
determined whether PED/PEA-15 up-regulation precedes
caspase 8 induction, we evaluated the levels of the two pro-
teins in NPCs at different time points after stimulation with
inflammatory cytokines. In line with their inability to sensi-
tize NPCs to DR-mediated apoptosis, inflammatory cyto-
kines induced a significant and stable increase in PED/PEA-15
expression in 12 h, whereas caspase 8 reached considerable
levels 24–48 h after stimulation (Fig. 5 E).
PED/PEA-15 contains a DED domain and inhibits DR-
mediated apoptosis by competing with caspase 8 for FADD
binding. To demonstrate the antiapoptotic activity of PED/
PEA-15 in NPCs, the CD95 DISC was analyzed in cells
pretreated with TNF-, IFN-, and IL-1 to induce cas-
pase 8 expression. Immunoblot analysis after CD95 im-
munoprecipitation showed a massive recruitment of PED/
Figure 5. Expression of DISC inhibitory
proteins in tissue-isolated embryonic and
adult NPCs. Immunoblot analysis of cFLIP
(A) and PED/PEA-15 (B) on NPCs, JY,
and 293T cell lines, the latter transfected
with Tween/cFLIP (293 FLIP) or Tween/
MYC-PED/PEA-15 (293 MYC-PED),
were used as positive control. Immunoblot
analysis of PED/PEA-15 in NPCs (C) and
NT2-neurons (D) untreated (Control) or
treated with TNF-, IFN-, and IL-1
alone or in combination (Mix). One repre-
sentative experiment out of three is shown.
(E) Immunoblot analysis of PED/PEA-15
and caspase 8 in NPCs at different time
points after stimulation with inflammatory
cytokines. Detection of -actin in the same
membrane blot served as loading control.
(F) Immunoprecipitation (IP) of the CD95
DISC in control () or CD95-stimulated
() NPCs treated with TNF-, IFN-, and
IL-1. CD95 was immunoprecipitated and
blot probed for CD95, caspase 8, FADD,
and PED/PEA-15. One representative ex-
periment out of four is shown.
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PEA-15 and FADD into the DISC of NPCs after CD95
stimulation, whereas caspase 8 was scarcely present (Fig. 5
F). To formally prove that PED/PEA-15 mediates DR re-
sistance in NPCs, PED/PEA-15 antisense was cloned in
the Tween lentiviral vector and transduced in NPCs. Flow
cytometry analysis of NPCs transduced with PED/PEA-15
antisense or control lentiviral vector showed that the len-
tiviral infection produced a virtually pure population of
GFP positive cells (Fig. 6 A). The expression of PED/
PEA-15 was subsequently monitored by immunoblot anal-
ysis in normal culture conditions or after exposure to TNF-,
IFN-, and IL-1. Transduction of NPCs with PED/
PEA-15 antisense considerably reduced PED/PEA-15 ex-
pression, both in basal conditions and after treatment with
inflammatory cytokines (Fig. 6 B). Accordingly, NPCs
transduced with PED/PEA-15 antisense acquired CD95
sensitivity and underwent caspase activation upon exposure
to inflammatory cytokines and anti-CD95 antibody, as
shown by caspase degradation (Fig. 6 C) and susceptibility
to apoptosis (Fig. 6 D). Thus, absence of caspase 8 and
PED/PEA-15 overexpression generate a double level of
protection from DR-mediated apoptosis in NPCs.
Discussion
For several years, one of the main dogmas in neuro-
science was based on the assumption that the nervous sys-
tem’s ability to recover from any kind of injury was due to
neuronal plasticity, but not regeneration. Recently, the dis-
covery of in-brain self-renewing populations of cells, po-
tentially capable of differentiating in functional mature
neurons and glial cells, has widened up the horizons in the
therapy of neurodegenerative disorders (3, 38, 39). How-
ever, a profound understanding of the biological behavior
of primitive neural cells is required to allow their manipula-
tion and therapeutic utilization.
Here, we have demonstrated that embryonic and adult
NPCs express functionally inactive DRs, whose binding by
their specific ligands does not generate apoptotic signals be-
cause of the absence of caspase 8. Although the extrinsic
apoptotic pathway controls the developmental production
and homeostasis of hematopoietic cells (40), the intrinsic
pathway is exploited during the development of the ner-
vous system to shape the brain through the activation of
programmed cell death in selected neural populations (41).
The absence of caspase 8 in primitive neural cells may con-
tribute to the developmental dependence on the intrinsic
pathway of neural cells, which accumulate abnormally in
embryos of mice lacking caspase 9 or its adaptor Apaf-1.
The refractoriness to the activation of the extrinsic path-
way in primitive neural cells may have considerable implica-
tions in adult neurogenesis. In several pathological condi-
tions, DR ligands exert a deleterious effect on neurons,
whereas NPCs migrate and survive in the site of lesion.
Brain injury creates in degenerating areas an inflammatory
environment that enhances neuronal death (23). The ability
of NPCs to survive in the damaged areas of the brain appar-
ently conflicts with the up-regulation of CD95 and caspase 8
Figure 6. PED/PEA-15–mediated pro-
tection of adult NPCs from CD95-induced
apoptosis. (A) Flow cytometry analysis of
GFP positive NPCs transduced with empty
Tween (Vector) or Tween/PED/PEA-15
antisense (PED/AS) vectors (gray), as com-
pared with nontransduced NPCs (black).
(B) Immunoblot analysis of PED/PEA-15
expression in NPCs transduced as in A, un-
treated or treated TNF-, IFN-, and IL-1
(Mix). (C) Caspase expression and degra-
dation in NPCs transduced with empty
Tween (Vector) or PED/AS and exposed to
anti-CD95 where indicated. (D) Percentage
of apoptosis in untransduced (Mock) and
empty Tween (Vector) or PED/AS trans-
duced NPCs exposed to anti-CD95 for 24
or 48 h. All samples in C and D were prein-
cubated with TNF-, IFN-, and IL-1
48–60 h before anti-CD95 stimulation. Re-
sults shown are representative of four inde-
pendent experiments with tissue-isolated
embryonic and adult NPCs.
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observed after their exposure to the inflammatory cytokines
that are commonly produced during acute brain lesions (23).
However, exogenous or cytokine-induced expression of
caspase 8 is not sufficient to prime primitive neural cells to
DR-mediated apoptosis, even in stimulatory conditions re-
sulting in massive neuronal death. After DR stimulation in
sensitive cells, caspase 8 undergoes an intramolecular refold-
ing responsible for its proteolytic activation as death signal
transducer. Primitive neural cells do not activate caspase 8
after DR triggering. Refractoriness to DR stimulation in
cells expressing all the different components of the apoptotic
machinery may result from the inability to recruit FADD or
caspase 8 into the DISC. Primitive neural cells express high
levels of PED/PEA-15, a DED domain containing protein
that binds the DED domain of FADD or caspase 8, thereby
preventing the recruitment of caspase 8 to the DISC and
subsequent activation of the apoptotic cascade. The antiapop-
totic role of PED/PEA-15 is particularly clear in NPCs ex-
posed to inflammatory cytokines, where the rapid increase
in PED/PEA-15 expression neutralizes the up-regulation of
CD95 and caspase 8. Although the ability of these cytokines
to modulate the expression of PED/PEA-15 has not been
explored before, this behavior seems to typically characterize
undifferentiated neural cells because the same cytokines
down-regulate PED/PEA-15 protein levels in NT2/D1-
derived neurons. Thus, it is likely that the modulation of
PED/PEA-15 by inflammatory cytokines differentially regu-
late the survival of primitive neural cells and their progeny.
The molecular basis underlying the opposite effects of in-
flammatory cytokines on PED/PEA-15 expression in primi-
tive neural cells and neurons should be a matter of investiga-
tion. A possible explanation may reside in the different
targets of the signals generated by inflammatory cytokines in
undifferentiated and differentiated cells. Because Akt-medi-
ated phosphorylation of PED/PEA-15 increases its protein
stability (42), the different activation of this kinase in mature
and immature cells represents a possible mechanism respon-
sible for the opposite effect on PED/PEA-15 expression.
The inflammatory products generated in the lesioned ar-
eas of the brain during acute pathological conditions may
impair neuronal cell survival, even without the contribu-
tion of DR triggering. However, high PED/PEA-15 ex-
pression in neural stem and progenitor cells may not exclu-
sively protect these cells from DR ligands, as PED/PEA-15
levels comparable or lower than those observed in primi-
tive neural cells have been shown to inhibit apoptosis in-
duced by growth factor deprivation, exposure to H2O2,
and anisomycin (43). Therefore, constitutive and cytokine-
induced PED/PEA-15 may theoretically contribute to pro-
mote the survival of primitive neural cells during oxidative
stress, inflammation, or growth factor deprivation. The
ability of PED/PEA-15 to circumvent the extrinsic death
signals makes it a suitable therapeutic target to enhance the
prosurvival response of injured differentiated neurons. Like-
wise, the capacity of the PI3K–Akt pathway to sustain the
levels of PED/PEA-15 may provide a further explanation
to the neuroprotective potential of PI3K–Akt-inducing
signals (42).
In conclusion, this work demonstrates that primitive
neural cells display a double level of protection from the
deadly activity of DR ligands, which are unable to deliver
apoptosis signals in these cells even in enhancing situations,
such as the inflammatory response typical of many neuro-
degenerative conditions. Thus, our results may explain the
ability of endogenous neural stem cells to survive in acute
brain injury. Although in vivo studies are required to con-
firm that the high expression of PED/PEA-15 and the ab-
sence of caspase 8 observed in vitro are relevant features of
NPCs, these findings may provide useful information for
therapeutic approaches exploiting the endogenous neuro-
genesis or based on delivery of neural stem or progenitor
cells to replace damaged neurons.
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